Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -263.2% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 28.5 | n/a |
Pr/Book | 2.1 |
Latest | F'cast | |
---|---|---|
Revenue | 40.9% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 0.74 | (2.49) | (2.56)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 1.52 | 5.71 | 6.65p | 8.7 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2.21 | 6.18 | 7.15p | 6.4 | 0.8 | +8% | n/a | 0.0% |
31-Dec-22 | 0.46 | 2.44 | 2.93p | 4.5 | n/a | -59% | n/a | 0.0% |
31-Dec-23 | 0.64 | (2.04) | (2.24)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
First order from US weight management brand | 15-Apr-2025 | 07:00 | RNS |
Holding(s) in Company | 07-Apr-2025 | 17:34 | RNS |
Commercial Update | 18-Mar-2025 | 07:00 | RNS |
£5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 18.56p |
Change Today | -0.19p |
% Change | -1.00 % |
52 Week High | 33.00 |
52 Week Low | 10.25 |
Volume | 50,879 |
Shares Issued | 97.94m |
Market Cap | £18.18m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:39 | 64 @ 18.00p |
09:07 | 2,000 @ 18.61p |
08:04 | 48,815 @ 19.30p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research